导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 5.59% | 394/1050 |
| 近一周 | 1.56% | 212/1104 |
| 近一月 | -9.27% | 911/1103 |
| 近一季 | 20.10% | 43/1094 |
| 近半年 | 7.54% | 316/1074 |
| 近一年 | -8.50% | 715/1020 |
| 近两年 | 33.46% | 652/926 |
| 近三年 | 4.47% | 636/834 |
| 成立以来 | 192.40% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.42% 451/1070 |
1.46% 671/1101 |
- - |
- - |
| 2025 | 17.03% 722/1065 |
6.04% 338/1014 |
9.00% 130/1038 |
17.33% 686/1050 |
-13.71% 964/1065 |
| 2024 | -14.85% 853/1011 |
-8.80% 732/960 |
-6.74% 730/983 |
9.32% 677/991 |
-8.42% 844/1011 |
| 2023 | -8.06% 278/952 |
4.14% 368/880 |
-1.74% 288/895 |
-7.15% 443/915 |
-3.23% 343/952 |
| 2022 | -21.18% 377/867 |
-11.59% 138/773 |
-1.94% 726/806 |
-16.18% 626/845 |
8.45% 108/867 |
| 2021 | 11.74% 220/740 |
7.42% 24/580 |
23.13% 113/659 |
-3.90% 309/704 |
-12.08% 670/740 |
| 2020 | 98.96% 35/554 |
26.90% 1/419 |
38.50% 35/466 |
0.59% 411/517 |
12.53% 269/554 |
| 2019 | 69.29% 45/410 |
33.89% 179/1146 |
1.98% 167/1228 |
15.32% 34/390 |
7.51% 260/410 |
| 2018 | -19.30% 63/349 |
- - |
0.25% 75/990 |
-15.77% 952/1000 |
-15.13% 882/1080 |
| 2017 | 24.80% 65/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 58.86% |
| 招商医药健康产业股票 | 2.7000 | 55.89% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 前海开源公共卫生股票C | 0.4741 | 45.97% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 广发医药精选股票C | 1.3346 | 44.45% |
| 嘉实医疗保健股票 | 2.6570 | 44.25% |
| 中欧医疗创新股票A | 1.6792 | 37.80% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 工银前沿医疗股票A VS. 东吴新产业精选股票A(580008) |